Percutaneous Coronary Intervention
Conditions
Keywords
Outcome after PCI, Middle Eastern Patients
Brief summary
The investigators will look at the short- (in hospital) and long- term ( 1 year)outcome in consecutive patients who undergo stent implantation and angioplasty in Jordan.
Detailed description
1. Voluntary registry of consecutive patients undergoing Percutaneous coronary intervention (PCI). 2. Patients will be treated according to the treating cardiologists' discretion. No randomization of any medication or stent. 3. Baseline data on admission will be collected (cardiovascular risk factors, blood lipids, ect). 4. PCI procedure details and complications will be documented during the index admission. 5. Outcome events (death, MI, revascularization, stent thrombosis) will be evaluated at 1, 6, and 12 months by clinic visits or phone calls.
Interventions
PROCEDUREProcedure: PCI
Sponsors
AstraZeneca
Jordan Collaborating Cardiology Group
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Consecutive PCI patients * Arab nationality
Exclusion criteria
* less than 18 year of age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular mortality | 1 year | All cases of deaths from cardiovascular causes will be counted at 1 year. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Admission for urgent coronary revascularization | 1 year | All events of hospital readmission for repeat coronary intervention for acute coronary syndrome from the time of discharge from hospital up to 1 year will be documented. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Stent thrombosis | 1 year | All cases of definite/probable/possible stent thrombosis will be documented from the time of stent implantation during the index admission to 1 year. |
| Baseline risk factors and outcome after 1 year | 1 year | Several factors at baseline will be evaluated as potential contributors to adverse outcome after one year, including: age, gender, renal impairment, heart failure, CRUSADE bleeding risc score, GRACE risk score, diabetes, multiple risk factors, BMI, and smoking. |
| Adherence to guidelines in patients undergoing PCI | 1 year | Using medications (statins, antiplatelets, ACI inhibitors/ARBs, B blockers, etc),and diagnostic and interventional procedures, and reaching target parameters (LDL cholesterol and HbA1c) according to the published guidelines will be evaluated. |
Countries
Jordan
Outcome results
None listed